Sign in

CIK 0000876343

  • Non-accelerated filer
  • Smaller reporting company

Lineage Cell Therapeutics, Inc.

Sign in to watch
Ticker
LCTX
Exchange
NYSE
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
CA
Entity type
Operating
EIN
943127919
Phone
+1 510-521-3390
Business address
2173 SALK AVENUE, SUITE 200, CARLSBAD, CA, 92008
Former names
BIOTIME INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2021-06-22 KINGSLEY ALFRED D Director Option exercise +61,800 $2.20 $136K 5,470,245
2021-06-22 KINGSLEY ALFRED D Director Option exercise · Stock Option (right to buy) −61,800 0
2021-06-21 Cook Kevin Leon Chief Financial Officer Grant or award · Employee Stock Option (right to buy) +750,000 750,000
2021-06-18 Mulroy Michael H. Director Option exercise +24,720 $2.20 $54K 251,555
2021-06-18 Mulroy Michael H. Director Option exercise · Stock Option (right to buy) −24,720 0
2021-05-04 Jayasuriya Anula Director Grant or award · Stock Option (Right to Buy) +90,000 90,000
2021-04-20 Amin Dipti Director Grant or award · Stock Option (Right to Buy) +90,000 90,000
2021-03-31 Culley Brian M President and CEO Option exercise +15,450 $2.35 $36K 201,052
2021-03-31 Culley Brian M President and CEO Shares withheld for taxes −5,343 $2.35 $13K 195,709
2021-03-31 Culley Brian M President and CEO Option exercise · Restricted Stock Units −15,450 77,250
2021-03-30 Hernandez Alexandra Sr Director Finance/Controller Option exercise +6,000 $0.69 $4K 6,000
2021-03-30 Hernandez Alexandra Sr Director Finance/Controller Sale −6,000 $2.23 $13K 0
2021-03-30 Hernandez Alexandra Sr Director Finance/Controller Option exercise · Employee Stock Option (Right to Buy) −6,000 39,200
2021-03-15 Hernandez Alexandra Sr Director Finance/Controller Grant or award · Employee Stock Option (Right to Buy) +42,700 42,700
2021-03-15 Culley Brian M President and CEO Grant or award · Employee Stock Option (Right to Buy) +1,165,100 1,165,100
2021-03-15 Leavitt Chase C. General Counsel/Secretary Grant or award · Employee Stock Option (Right to Buy) +699,100 699,100
2021-03-15 Hogge Gary S. SVP,Clinical & Medical Affairs Grant or award · Employee Stock Option (Right to Buy) +419,500 419,500
2020-12-31 Culley Brian M President and CEO Option exercise +15,450 $1.76 $27K 190,945
2020-12-31 Culley Brian M President and CEO Shares withheld for taxes −5,343 $1.76 $9K 185,602
2020-12-31 Culley Brian M President and CEO Option exercise · Restricted Stock Units −15,450 92,700

Page 9 of 17 · 322 trades